Abiopharma

New Form DEF 14A - PULSE BIOSCIENCES, INC. Filed: 2025-10-28 AccNo: 0001437749-25-031837 Size: 2 MB

New Form D - Tango Therapeutics, Inc. Filed: 2025-10-28 AccNo: 0001819133-25-000003 Size: 12 KB

New Form 6-K - ASTRAZENECA PLC Filed: 2025-10-28 AccNo: 0001654954-25-012271 Size: 17 KB

New Form DEFA14A - DYNATRONICS CORP Filed: 2025-10-28 AccNo: 0001062993-25-016324 Size: 655 KB

New Form SC TO-T/A - Tourmaline Bio, Inc. Filed: 2025-10-28 AccNo: 0001104659-25-102943 Size: 101 KB

New Form DEF 14A - DYNATRONICS CORP Filed: 2025-10-28 AccNo: 0001062993-25-016322 Size: 1 MB

Director CAPELLO JEFFREY D 🟡 adjusted position in 0 shares (1 derivative) of NEOGEN CORP (NEOG) at $6.19 Transaction Date: Oct 27, 2025 | Filing ID: 000060

Director BOREL JAMES C 🟡 adjusted position in 0 shares (1 derivative) of NEOGEN CORP (NEOG) at $6.19 Transaction Date: Oct 27, 2025 | Filing ID: 000059

(99% Neutral) Celularity Inc. (CELUW) Announces Business Combination

(19% Negative) ENVOY MEDICAL, INC. (COCH) Announces Delay in request Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review